Funding Support

Supporting requests for access to ECP services

We can support you in a number of ways, including providing:

Financial impact models that can help calculate the potential cost implications of introducing THERAKOS ECP ImmunomodulationTM.

Comprehensive business cases that can help support clinical governance and funding approval.

Access to new or transferable budget impact data to show how ECP may help reduce costs.

Insights and advice on economic and medical documentation.

Health technology assessment (HTA) submission support

Our qualified teams understand the complexities of the EU regulatory environment, so we are well placed to help with tasks such as preparing evidence dossiers for submission to HTA authorities.


Tailoring support to your needs

Because the needs of every healthcare unit are different, we offer flexible contracting options and practical ways to adapt to the demands of your unique environment.

For Patient and Funding Access Support, please contact your local territory manager or use the following email to explain your local or national health economic needs.

Contact Us

ECP, extracorporeal photopheresis; EU, European Union; HTA, health technology assessment.